What is NLST?
The National Cancer Institute (NCI) and ACRIN are sponsoring a nationwide study of Americans age 55-74 who have a history of long-time and/or heavy cigarette smoking. The study is called the National Lung Screening Trial (NLST). The purpose of NLST is to compare two ways of detecting lung cancer: standard chest x-ray versus CAT scan. Both chest x-rays and CAT scans are used in an effort to find lung cancer early. So far, neither chest x-rays nor CAT scans have been shown to reduce a person's chance of dying from this disease. NLST will need to screen 50,000 healthy men and women from all over the country to answer this question.
What are the Benefits?
All participants will receive a free lung-screening exam. The hope is that in the unlikely event that lung cancer is detected it will be at an early stage when treatment can be more effective.
|
In the News
Francine Jacobson was recently interviewed by the BWH Pike Notes crew about the anniversary of the NLST and how the Brigham has contribution to this important, nationwide study in the early detection of lung cancer.
|
Click here for the Spanish version
For More Information
(617) 732-NLST
NLST@partners.org
Philip Costello, MD, Principal Investigator
Francine Jacobson, MD, Co-Investgator
Annmarie Walsh, MAT, Research Study Coordinator
Voula Christopoulos, BS, Research Study Coordinator
Iva Kazda, DDS MPH, Research Assistant
Sophie Costello, Research Assistant
Send Feedback to: 
